These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 28803067)
21. Epithelial Mesenchymal Transition in Aggressive Lung Cancers. Mittal V Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798 [TBL] [Abstract][Full Text] [Related]
22. Loss of TP53I11 Enhances the Extracellular Matrix-independent Survival by Promoting Activation of AMPK. Xiao T; Xu Z; Zhou Y; Zhang H; Geng J; Liang Y; Qiao H; Suo G IUBMB Life; 2019 Feb; 71(2):183-191. PubMed ID: 30376610 [TBL] [Abstract][Full Text] [Related]
23. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer. Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393 [TBL] [Abstract][Full Text] [Related]
24. SIRT1 is highly expressed in brain metastasis tissues of non-small cell lung cancer (NSCLC) and in positive regulation of NSCLC cell migration. Han L; Liang XH; Chen LX; Bao SM; Yan ZQ Int J Clin Exp Pathol; 2013; 6(11):2357-65. PubMed ID: 24228097 [TBL] [Abstract][Full Text] [Related]
25. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway. Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760 [TBL] [Abstract][Full Text] [Related]
26. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207 [TBL] [Abstract][Full Text] [Related]
27. Feed-Forward Reciprocal Activation of PAFR and STAT3 Regulates Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer. Chen J; Lan T; Zhang W; Dong L; Kang N; Zhang S; Fu M; Liu B; Liu K; Zhan Q Cancer Res; 2015 Oct; 75(19):4198-210. PubMed ID: 26359459 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of RON in small and non-small cell lung cancers. Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712 [TBL] [Abstract][Full Text] [Related]
29. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929 [TBL] [Abstract][Full Text] [Related]
30. Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer. Tang D; Zhao YC; Qian D; Liu H; Luo S; Patz EF; Moorman PG; Su L; Shen S; Christiani DC; Glass C; Gao W; Wei Q Mol Carcinog; 2020 Jan; 59(1):104-115. PubMed ID: 31713888 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1. Mao M; Wu Z; Chen J Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872 [TBL] [Abstract][Full Text] [Related]
32. Quercetin suppresses the metastatic ability of lung cancer through inhibiting Snail-dependent Akt activation and Snail-independent ADAM9 expression pathways. Chang JH; Lai SL; Chen WS; Hung WY; Chow JM; Hsiao M; Lee WJ; Chien MH Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1746-1758. PubMed ID: 28648644 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity. Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415 [TBL] [Abstract][Full Text] [Related]
34. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis. Sun L; Li H; Chen J; Dehennaut V; Zhao Y; Yang Y; Iwasaki Y; Kahn-Perles B; Leprince D; Chen Q; Shen A; Xu Y J Natl Cancer Inst; 2013 Jun; 105(12):887-98. PubMed ID: 23704280 [TBL] [Abstract][Full Text] [Related]
35. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer. Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090 [TBL] [Abstract][Full Text] [Related]
36. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC). Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823 [TBL] [Abstract][Full Text] [Related]
37. Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells. Gao D; Wang L; Zhang H; Yan X; Yang J; Zhou R; Chang X; Sun Y; Tian S; Yao Z; Zhang K; Liu Z; Ma Z FEBS J; 2018 Nov; 285(22):4229-4245. PubMed ID: 30251328 [TBL] [Abstract][Full Text] [Related]
38. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC. Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786 [TBL] [Abstract][Full Text] [Related]
39. TFAP2C-mediated upregulation of TGFBR1 promotes lung tumorigenesis and epithelial-mesenchymal transition. Kim W; Kim E; Lee S; Kim D; Chun J; Park KH; Youn H; Youn B Exp Mol Med; 2016 Nov; 48(11):e273. PubMed ID: 27885255 [TBL] [Abstract][Full Text] [Related]
40. Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity. Nam A; Jain S; Wu C; Campos A; Shepard RM; Yu Z; Reddy JP; Von Schalscha T; Weis SM; Onaitis M; Wettersten HI; Cheresh DA Cancer Res; 2024 May; 84(10):1630-1642. PubMed ID: 38588407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]